CLIN.L Share News (CLIN)

UK Earnings, Trading Statements Calendar - Next 7 Days

Sunday newspaper round-up: More 'Nissan' deals, Carney, RBS, HSBC, Capita

(ShareCast News) - Pharmaceuticals giants want the government to plug a £1bn-a-year funding gap that will be created when Britain leaves the EU, as part of a list of demands being drawn up by big business after last week's deal with Nissan. After the Japanese car maker said it would make two new mod

Clinigen Group extends partnership with BTG

(ShareCast News) - AIM-listed pharmaceutical Clinigen Group's Idis Global Access division extended its four-year partnership with BTG, a healthcare company, to manage its critical care portfolio across the whole of Europe and new territories in Asia. The agreement now includes all of Europe and some

Clinigen Group Extends Exclusive Supply Agreement With BTG

Clinigen expands operations into Japan

(ShareCast News) - Clinigen Group, an AIM listed global pharmaceuticals and services company, has extended its geographical reach to Japan with the opening of a new office in Tokyo. Clinigen KK further expands the group's presence in Asia following the company's acquisition of Link healthcare in 201

Clinigen Opens Tokyo Office To Take Foscavir Marketing Back In-House

DIRECTOR DEALINGS SUMMARY: Clinigen Executive Slashes Shareholding

WINNERS & LOSERS SUMMARY: UK Mail Jumps On Deutsche Post Cash Offer

Clinigen Group issues 38k option shares

(ShareCast News) - Clinigen Group announced on Friday that it has made an application for the admission to trading on AIM of 38,308 ordinary shares of 0.1p each. The firm said the shares have been issued to satisfy the exercise of share options, and rank pari passu with the existing shares of the gr

Clinigen revenue and profits see serious rise

(ShareCast News) - Global pharmaceutical and services company Clinigen Group posted a trading update for the year to 30 June on Wednesday, reporting an 87% improvement in revenue and a 90% increase in gross profit. The AIM-traded firm said the growth was driven primarily by acquisitions and organic

WINNERS & LOSERS SUMMARY: Man Group Down As CEO Departs For PIMCO

Clinigen Revenue And Profit Surge On Acquisitions, Organic Growth

UK Earnings, Trading Statements Calendar - Next 7 Days

Clinigen Group Issues 83,016 Shares In Option Exercise (ALLISS)

Clinigen teams up with Horizon on RAVICTI

(ShareCast News) - Clinigen Group was celebrating on Wednesday, as its Idis Managed Access division and Nasdaq-traded Horizon Pharma initiated a Managed Access Programme in Europe for Horizon's RAVICTI oral liquid. The AIM-traded firm said RAVICTI received centralised marketing approval from the Eur